サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1544390

自己免疫薬の世界市場、2024～2028年

Global Autoimmune Drugs Market 2024-2028
出版日: | 発行: TechNavio | ページ情報: 英文 185 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
自己免疫薬の世界市場、2024～2028年
出版日: 2024年07月22日
発行: TechNavio
ページ情報: 英文 185 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

自己免疫薬市場は2023～2028年に332億1,880万米ドル、予測期間中のCAGRは6.78%で成長すると予測されます。

当レポートでは、自己免疫薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、強力な研究開発パイプライン、生物製剤の標的治療メカニズム、手頃なバイオシミラーの採用よって牽引されています。

市場範囲
基準年 2024年
終了年 2028年
予測期間 2024～2028年
成長モメンタム 加速
前年比[2024年] 6.23%
CAGR 6.78%
増分額 332億1,880万米ドル

本調査では、自己免疫薬のコスト削減が、今後数年間の自己免疫薬市場成長を牽引する主要因の1つであるとしています。また、TNFα阻害剤による市場の支配や新薬の市場開拓と承認は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第3章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023年
  • 市場の展望 2023～2028年

第4章 市場規模実績

  • 自己免疫薬の世界市場 2018～2022年
  • 治療領域別セグメント分析 2018～2022年
  • 流通チャネル別セグメント分析 2018～2022年
  • 地域別セグメント分析 2018～2022年
  • 国別セグメント分析 2018～2022年

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション：治療領域別

  • 市場セグメンテーション
  • 比較：治療領域別
  • 関節リウマチ：市場規模と予測 2023～2028年
  • 多発性硬化症：市場規模と予測 2023～2028年
  • 乾癬：市場規模と予測 2023～2028年
  • 炎症性腸疾患：市場規模と予測 2023～2028年
  • その他：市場規模と予測 2023～2028年
  • 市場機会：治療領域別

第7章 市場セグメンテーション：流通チャネル別

  • 市場セグメンテーション
  • 比較：流通チャネル別
  • 病院：市場規模と予測 2023～2028年
  • 薬局：市場規模と予測 2023～2028年
  • ドラッグストア/薬局：市場規模と予測 2023～2028年
  • オンライン：市場規模と予測 2023～2028年
  • 市場機会：流通チャネル別

第8章 顧客情勢

  • 顧客情勢概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 比較：地域別
  • 北米：市場規模と予測 2023～2028年
  • 欧州：市場規模と予測 2023～2028年
  • アジア：市場規模と予測 2023～2028年
  • その他：市場規模と予測 2023～2028年
  • 米国：市場規模と予測 2023～2028年
  • ドイツ：市場規模と予測 2023～2028年
  • カナダ：市場規模と予測 2023～2028年
  • 中国：市場規模と予測 2023～2028年
  • 英国：市場規模と予測 2023～2028年
  • 市場機会：地域情勢別

第10章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第11章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第12章 競合分析

  • 企業プロファイル
  • 企業の市場ポジショニング
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol Myers Squibb Co.
  • Cardinal Health Inc.
  • Delphis Pharmaceutical India
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals Plc
  • Johnson and Johnson Services Inc.
  • Parvus Therapeutics Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Autoimmune Drugs Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on Therapy Area - Market share 2023-2028 (%)
  • Exhibits33: Data Table on Therapy Area - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by Therapy Area
  • Exhibits35: Data Table on Comparison by Therapy Area
  • Exhibits36: Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Psoriasis - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Psoriasis - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Chart on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
  • Exhibits49: Data Table on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
  • Exhibits50: Chart on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
  • Exhibits51: Data Table on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
  • Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Market opportunity by Therapy Area ($ million)
  • Exhibits57: Data Table on Market opportunity by Therapy Area ($ million)
  • Exhibits58: Chart on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits59: Data Table on Distribution Channel - Market share 2023-2028 (%)
  • Exhibits60: Chart on Comparison by Distribution Channel
  • Exhibits61: Data Table on Comparison by Distribution Channel
  • Exhibits62: Chart on Hospital - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Data Table on Hospital - Market size and forecast 2023-2028 ($ million)
  • Exhibits64: Chart on Hospital - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Data Table on Hospital - Year-over-year growth 2023-2028 (%)
  • Exhibits66: Chart on Pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Data Table on Pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibits68: Chart on Pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Data Table on Pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits70: Chart on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Data Table on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
  • Exhibits72: Chart on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Data Table on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
  • Exhibits74: Chart on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Data Table on Online - Market size and forecast 2023-2028 ($ million)
  • Exhibits76: Chart on Online - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Data Table on Online - Year-over-year growth 2023-2028 (%)
  • Exhibits78: Market opportunity by Distribution Channel ($ million)
  • Exhibits79: Data Table on Market opportunity by Distribution Channel ($ million)
  • Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits81: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits83: Chart on Geographic comparison
  • Exhibits84: Data Table on Geographic comparison
  • Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits106: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits107: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits114: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits115: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits118: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits119: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits120: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits121: Market opportunity By Geographical Landscape ($ million)
  • Exhibits122: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits123: Impact of drivers and challenges in 2023 and 2028
  • Exhibits124: Overview on criticality of inputs and factors of differentiation
  • Exhibits125: Overview on factors of disruption
  • Exhibits126: Impact of key risks on business
  • Exhibits127: Companies covered
  • Exhibits128: Matrix on companies position and classification
  • Exhibits129: AbbVie Inc. - Overview
  • Exhibits130: AbbVie Inc. - Product / Service
  • Exhibits131: AbbVie Inc. - Key news
  • Exhibits132: AbbVie Inc. - Key offerings
  • Exhibits133: Amgen Inc. - Overview
  • Exhibits134: Amgen Inc. - Product / Service
  • Exhibits135: Amgen Inc. - Key news
  • Exhibits136: Amgen Inc. - Key offerings
  • Exhibits137: AstraZeneca Plc - Overview
  • Exhibits138: AstraZeneca Plc - Product / Service
  • Exhibits139: AstraZeneca Plc - Key news
  • Exhibits140: AstraZeneca Plc - Key offerings
  • Exhibits141: Bristol Myers Squibb Co. - Overview
  • Exhibits142: Bristol Myers Squibb Co. - Product / Service
  • Exhibits143: Bristol Myers Squibb Co. - Key news
  • Exhibits144: Bristol Myers Squibb Co. - Key offerings
  • Exhibits145: Cardinal Health Inc. - Overview
  • Exhibits146: Cardinal Health Inc. - Business segments
  • Exhibits147: Cardinal Health Inc. - Key news
  • Exhibits148: Cardinal Health Inc. - Key offerings
  • Exhibits149: Cardinal Health Inc. - Segment focus
  • Exhibits150: Delphis Pharmaceutical India - Overview
  • Exhibits151: Delphis Pharmaceutical India - Product / Service
  • Exhibits152: Delphis Pharmaceutical India - Key offerings
  • Exhibits153: Eli Lilly and Co. - Overview
  • Exhibits154: Eli Lilly and Co. - Product / Service
  • Exhibits155: Eli Lilly and Co. - Key news
  • Exhibits156: Eli Lilly and Co. - Key offerings
  • Exhibits157: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits158: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits159: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits160: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits161: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits162: GlaxoSmithKline Plc - Overview
  • Exhibits163: GlaxoSmithKline Plc - Business segments
  • Exhibits164: GlaxoSmithKline Plc - Key news
  • Exhibits165: GlaxoSmithKline Plc - Key offerings
  • Exhibits166: GlaxoSmithKline Plc - Segment focus
  • Exhibits167: Hikma Pharmaceuticals Plc - Overview
  • Exhibits168: Hikma Pharmaceuticals Plc - Business segments
  • Exhibits169: Hikma Pharmaceuticals Plc - Key news
  • Exhibits170: Hikma Pharmaceuticals Plc - Key offerings
  • Exhibits171: Hikma Pharmaceuticals Plc - Segment focus
  • Exhibits172: Johnson and Johnson Services Inc. - Overview
  • Exhibits173: Johnson and Johnson Services Inc. - Business segments
  • Exhibits174: Johnson and Johnson Services Inc. - Key news
  • Exhibits175: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits176: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits177: Parvus Therapeutics Inc. - Overview
  • Exhibits178: Parvus Therapeutics Inc. - Product / Service
  • Exhibits179: Parvus Therapeutics Inc. - Key offerings
  • Exhibits180: Sanofi SA - Overview
  • Exhibits181: Sanofi SA - Business segments
  • Exhibits182: Sanofi SA - Key news
  • Exhibits183: Sanofi SA - Key offerings
  • Exhibits184: Sanofi SA - Segment focus
  • Exhibits185: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits186: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits187: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits188: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits189: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits190: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits191: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits192: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits193: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits194: Inclusions checklist
  • Exhibits195: Exclusions checklist
  • Exhibits196: Currency conversion rates for US$
  • Exhibits197: Research methodology
  • Exhibits198: Information sources
  • Exhibits199: Data validation
  • Exhibits200: Validation techniques employed for market sizing
  • Exhibits201: Data synthesis
  • Exhibits202: 360 degree market analysis
  • Exhibits203: List of abbreviations
目次
Product Code: IRTNTR70662

The autoimmune drugs market is forecasted to grow by USD 33218.8 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong R&D pipeline, targeted therapeutic mechanism of biologics, and introduction of affordable biosimilars.

Technavio's autoimmune drugs market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.23%
CAGR6.78%
Incremental Value$33218.8 mn

By Therapy Area

    • Rheumatoid arthritis
    • Multiple sclerosis
    • Psoriasis
    • Inflammatory bowel disease
    • Others

By Distribution Channel

    • Hospital
    • Pharmacy
    • Drug store/Retail pharmacy
    • Online

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the reduction in cost of autoimmune drugs as one of the prime reasons driving the autoimmune drugs market growth during the next few years. Also, market dominance by TNF-alpha inhibitors and development and approval of new drugs will lead to sizable demand in the market.

The report on the autoimmune drugs market covers the following areas:

    • Autoimmune drugs market sizing
    • Autoimmune drugs market forecast
    • Autoimmune drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune drugs market vendors that include AbbVie Inc., AdvaCare Pharma, Amgen Inc., AstraZeneca PLC, Bristol Myers Squibb Co., Cardinal Health Inc., Delphis Pharmaceutical India, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Medexus Pharmaceuticals Inc., Parvus Therapeutics Inc., Prometheus Laboratories, Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Wellona Pharma. Also, the autoimmune drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Therapy Area
    • Executive Summary - Chart on Market Segmentation by Distribution Channel
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Autoimmune Drugs Market 2018 - 2022
    • Historic Market Size - Data Table on Global Autoimmune Drugs Market 2018 - 2022 ($ million)
  • 4.2 Therapy Area segment analysis 2018 - 2022
    • Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
  • 4.3 Distribution Channel segment analysis 2018 - 2022
    • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy Area

  • 6.1 Market segments
    • Chart on Therapy Area - Market share 2023-2028 (%)
    • Data Table on Therapy Area - Market share 2023-2028 (%)
  • 6.2 Comparison by Therapy Area
    • Chart on Comparison by Therapy Area
    • Data Table on Comparison by Therapy Area
  • 6.3 Rheumatoid arthritis - Market size and forecast 2023-2028
    • Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
    • Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
    • Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
  • 6.4 Multiple sclerosis - Market size and forecast 2023-2028
    • Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
    • Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
    • Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
    • Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
  • 6.5 Psoriasis - Market size and forecast 2023-2028
    • Chart on Psoriasis - Market size and forecast 2023-2028 ($ million)
    • Data Table on Psoriasis - Market size and forecast 2023-2028 ($ million)
    • Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
    • Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
  • 6.6 Inflammatory bowel disease - Market size and forecast 2023-2028
    • Chart on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
    • Data Table on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
    • Chart on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
    • Data Table on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
  • 6.7 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.8 Market opportunity by Therapy Area
    • Market opportunity by Therapy Area ($ million)
    • Data Table on Market opportunity by Therapy Area ($ million)

7 Market Segmentation by Distribution Channel

  • 7.1 Market segments
    • Chart on Distribution Channel - Market share 2023-2028 (%)
    • Data Table on Distribution Channel - Market share 2023-2028 (%)
  • 7.2 Comparison by Distribution Channel
    • Chart on Comparison by Distribution Channel
    • Data Table on Comparison by Distribution Channel
  • 7.3 Hospital - Market size and forecast 2023-2028
    • Chart on Hospital - Market size and forecast 2023-2028 ($ million)
    • Data Table on Hospital - Market size and forecast 2023-2028 ($ million)
    • Chart on Hospital - Year-over-year growth 2023-2028 (%)
    • Data Table on Hospital - Year-over-year growth 2023-2028 (%)
  • 7.4 Pharmacy - Market size and forecast 2023-2028
    • Chart on Pharmacy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Pharmacy - Market size and forecast 2023-2028 ($ million)
    • Chart on Pharmacy - Year-over-year growth 2023-2028 (%)
    • Data Table on Pharmacy - Year-over-year growth 2023-2028 (%)
  • 7.5 Drug store/retail pharmacy - Market size and forecast 2023-2028
    • Chart on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
    • Chart on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
    • Data Table on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
  • 7.6 Online - Market size and forecast 2023-2028
    • Chart on Online - Market size and forecast 2023-2028 ($ million)
    • Data Table on Online - Market size and forecast 2023-2028 ($ million)
    • Chart on Online - Year-over-year growth 2023-2028 (%)
    • Data Table on Online - Year-over-year growth 2023-2028 (%)
  • 7.7 Market opportunity by Distribution Channel
    • Market opportunity by Distribution Channel ($ million)
    • Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.9 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
  • 12.4 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
  • 12.5 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
  • 12.6 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
  • 12.7 Cardinal Health Inc.
    • Cardinal Health Inc. - Overview
    • Cardinal Health Inc. - Business segments
    • Cardinal Health Inc. - Key news
    • Cardinal Health Inc. - Key offerings
    • Cardinal Health Inc. - Segment focus
  • 12.8 Delphis Pharmaceutical India
    • Delphis Pharmaceutical India - Overview
    • Delphis Pharmaceutical India - Product / Service
    • Delphis Pharmaceutical India - Key offerings
  • 12.9 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key news
    • Eli Lilly and Co. - Key offerings
  • 12.10 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 12.11 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
  • 12.12 Hikma Pharmaceuticals Plc
    • Hikma Pharmaceuticals Plc - Overview
    • Hikma Pharmaceuticals Plc - Business segments
    • Hikma Pharmaceuticals Plc - Key news
    • Hikma Pharmaceuticals Plc - Key offerings
    • Hikma Pharmaceuticals Plc - Segment focus
  • 12.13 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
  • 12.14 Parvus Therapeutics Inc.
    • Parvus Therapeutics Inc. - Overview
    • Parvus Therapeutics Inc. - Product / Service
    • Parvus Therapeutics Inc. - Key offerings
  • 12.15 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
  • 12.16 Takeda Pharmaceutical Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd. - Overview
    • Takeda Pharmaceutical Co. Ltd. - Product / Service
    • Takeda Pharmaceutical Co. Ltd. - Key news
    • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 12.17 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
    • 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations